Shares of Baxter International Inc (NYSE:BAX) ended Thursday session in green amid volatile trading. The shares closed up +0.28 points or 0.58% at $48.20 with 5.58 million shares getting traded. Post opening the session at $48.08, the shares hit an intraday low of $48.00 and an intraday high of $48.26 and the price vacillated in this range throughout the day. The company has a market cap of $26.51 billion and the numbers of outstanding shares have been calculated to be 543.89 million shares.
On September 22, 2016 Driving Your Health (Manejando tu Salud), a mobile health program that deploys medical teams to communities in Mexico City with limited access to health services, was launched by The Baxter International Foundation and the global humanitarian organization Direct Relief.
”This unique collaboration brings healthcare services directly to those who are unable to access care due to lack of transportation, the cost of transportation or the inability to take time off from work to get their healthcare needs addressed,” said Stacey Eisen, Baxter International Foundation President. ”The Foundation is proud to be able to support the local community in this way and bring quality healthcare to more people.”
Funded by a $2.25 million grant from the Baxter International Foundation — and working in collaboration with the Mexican Association of Malta, House of Friendship for Children with Cancer I.A.P. and Mexican Association of Diabetes, Mexico City A.C. — the three-year initiative aims to provide direct healthcare services for 40,000 patients and health education, prevention, and awareness training to an additional 310,000 individuals.
Although Mexico City and the State of Mexico overall have higher living standards than many regions of the country, they have pockets of extreme poverty with many individuals who are often disconnected from available health services.
”Driving Your Health recognizes that, for too many people, the benefits of healthcare are beyond reach, and that new approaches are needed,” said Thomas Tighe, Direct Relief president and CEO. ”Direct Relief is delighted to collaborate with Baxter on this initiative to improve the health and lives of those in need.”
Shares of Tokai Pharmaceuticals Inc (NASDAQ:TKAI) ended Thursday session in green amid volatile trading. The shares closed up +0.31 points or 23.13% at $1.65 with 5.47 million shares getting traded. Post opening the session at $1.37, the shares hit an intraday low of $1.31 and an intraday high of $1.79 and the price vacillated in this range throughout the day. The company has a market cap of $36.80 million and the numbers of outstanding shares have been calculated to be 22.63 million shares.
Tokai Pharmaceuticals Inc (TKAI), a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate is galeterone, an oral small molecule that is in various clinical trials for the treatment of patients with metastatic castration-resistant prostate cancer. The companys androgen receptor degradation (ARDA) drug discovery program is focused on identifying and developing compounds for ARDA activity. Tokai Pharmaceuticals, Inc. was founded in 2004 and is based in Boston, Massachusetts.